Glass House Brands (GLAS) Operating Income (2020 - 2026)
Glass House Brands (GLAS) posted quarterly Operating Income of -$14.4 million for Q1 2026, down 13.13% quarter-over-quarter from -$12.7 million in Q4 2025.
Glass House Brands (GLAS) Operating Income (2020 - 2026) Analysis & Trends
Glass House Brands (GLAS) has reported Operating Income for 7 consecutive years, with -$14.4 million the latest figure, recorded in Q1 2026.
- In Q1 2026, Operating Income changed N/A year-over-year to -$14.4 million; the TTM figure through Mar 2026 stood at -$27.8 million (changed N/A YoY), while the FY2025 annual figure was -$16.5 million, down 388.18% from the prior year.
- Operating Income retreated to -$14.4 million in Q1 2026 per GLAS's latest filing, from -$12.7 million in the prior quarter.
- Across five years, Operating Income topped out at $33.2 million in Q4 2023 and bottomed at -$14.4 million in Q1 2026.
- Historically, Operating Income has averaged $4.1 million across 5 years, with a median of $4.9 million in 2023.
- On a YoY basis, Operating Income climbed as much as 1621.74% in 2022 and fell as far as 177.5% in 2022.
- Glass House Brands' Operating Income stood at $16.5 million in 2022, then soared by 101.02% to $33.2 million in 2023, then sank by 84.8% to $5.0 million in 2024, then sank by 351.52% to -$12.7 million in 2025, then decreased by 13.13% to -$14.4 million in 2026.
- Business Quant data shows GLAS's Operating Income at -$14.4 million in Q1 2026, -$12.7 million in Q4 2025, and -$11.4 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Op. Inc (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.65 Bn | 42.68 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 43.09 Bn | 39.44 Bn | 2.15 Bn | -231.00 Mn |
| 3 | Zoetis | 31.54 Bn | 29.86 Bn | 1.05 Bn | 837.00 Mn |
| 4 | Takeda Pharmaceutical | 28.61 Bn | 22.81 Bn | 5.10 Bn | 1.26 Bn |
| 5 | United Therapeutics | 22.11 Bn | 19.45 Bn | 683.80 Mn | 330.80 Mn |
| 6 | Viatris | 18.77 Bn | 17.88 Bn | 1.46 Bn | 6.30 Mn |
| 7 | Neurocrine Biosciences | 15.62 Bn | 15.23 Bn | 935.80 Mn | 151.50 Mn |
| 8 | Elanco Animal Health | 12.07 Bn | 11.54 Bn | 798.00 Mn | 248.00 Mn |
| 9 | Dr Reddys Laboratories | 10.09 Bn | 9.93 Bn | - | - |
| 10 | Glass House Brands | 835.49 Mn | 816.93 Mn | 15.77 Mn | -3.00 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -14.35 Mn |
| Dec 31, 2025 | -12.68 Mn |
| Sep 30, 2025 | -11.38 Mn |
| Jun 30, 2025 | 10.64 Mn |
| Jun 30, 2024 | 5.04 Mn |
| Dec 31, 2023 | 33.17 Mn |
| Sep 30, 2023 | 4.89 Mn |
| Jun 30, 2023 | 3.22 Mn |
| Mar 31, 2023 | 24.47 Mn |
| Dec 31, 2022 | 16.50 Mn |
| Sep 30, 2022 | -9.90 Mn |
| Jun 30, 2022 | 17.03 Mn |
| Mar 31, 2022 | -13.76 Mn |
| Dec 31, 2021 | -19.67 Mn |
| Sep 30, 2021 | -9.52 Mn |
| Jun 30, 2021 | 989,000.00 |
| Mar 31, 2021 | -4.96 Mn |
| Dec 31, 2020 | -741,353.00 |
| Sep 30, 2020 | -1.15 Mn |
| Mar 31, 2020 | -4.18 Mn |